LLY
Eli Lilly and Company
LLY has the edge over PYPL overall, supported by stronger fundamentals and stronger modeled upside.
PYPL
PayPal Holdings, Inc.
PYPL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
PYPL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
PYPL's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PYPL.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
PYPL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.9x | $58.30 | — |
| Current | 11x | $58.30 | — |
| Cheap | 15x | $76.16 | +31% |
| Fair | 26x | $136 | +133% |
| Expensive | 67x | $351 | +503% |
Historical ranges are pointers, not guarantees.
PYPL has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over PYPL on the outlook, with more favorable revenue expectations.
PYPL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect PYPL's earnings to grow and its profitability to improve, with its revenue holding steady.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over PYPL on earnings, with stronger typical year-over-year growth.
PYPL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.87 | +12% |
| Q3 2026 | $5.24 | +5.4% |
| Q2 2026 | $5.29 | +14% |
| Q1 2026 | $5.33 | +20% |
| Q4 2025 | $5.41 | +36% |
| Q3 2025 | $4.97 | +19% |
| Q2 2025 | $4.66 | +13% |
| Q1 2025 | $4.45 | +12% |
| Q4 2024 | $3.99 | +3.9% |
PYPL's earnings per share have climbed steadily: $5.24 over the past year, up 5.4% from the year before, and higher year over year for 14 quarters in a row.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over PYPL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over PYPL on profitability, with a higher operating margin.
PYPL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6B | +2% |
| Q2 2026 | $8.7B | +4.8% |
| Q1 2026 | $8.4B | +7.2% |
| Q4 2025 | $8.7B | +3.7% |
| Q3 2025 | $8.4B | +7.3% |
| Q2 2025 | $8.3B | +5.1% |
| Q1 2025 | $7.8B | +1.2% |
| Q4 2024 | $8.4B | +4.2% |
PYPL's revenue has grown year over year every quarter since late 2020: $8.6B last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -1.7 points |
| Q1 2026 | 18% | -1.8 points |
| Q4 2025 | 17% | +0.2 points |
| Q3 2025 | 18% | +0.3 points |
| Q2 2025 | 18% | +1.3 points |
| Q1 2025 | 20% | +4.5 points |
| Q4 2024 | 17% | -4.3 points |
PYPL's operating margin was 16% last quarter, down 1.7 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over PYPL on cash flow, with more consistent year-over-year improvement.
PYPL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -17% |
| Q2 2026 | $1.8B | +157% |
| Q1 2026 | $903M | -6.3% |
| Q4 2025 | $2.2B | 0% |
| Q3 2025 | $1.7B | +19% |
| Q2 2025 | $692M | -49% |
| Q1 2025 | $964M | -45% |
| Q4 2024 | $2.2B | -11% |
PYPL's free cash flow was $6.3B over the past year, up 13% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PYPL.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
PYPL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.7% | -24M shares |
| 1 year | -11% | -102M shares |
| 3 years | -22% | -240M shares |
| 5 years | -28% | -329M shares |
| Available history | -28% | -329M shares |
PYPL has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5B |
| Q2 2026 | $1.6B |
| Q1 2026 | $1.5B |
| Q4 2025 | $1.5B |
| Q3 2025 | $1.5B |
| Q2 2025 | $1.6B |
| Q1 2025 | $1.5B |
| Q4 2024 | $1.3B |
PYPL spent $6.1B buying back its own shares over the past year, up 4% from the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
PYPL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.5x | Very low |
PYPL has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
PYPL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.2 | Neutral |
| Stochastic | 61.9 | Neutral |
PYPL's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
PYPL PE vs Financial Services Sector
| Metric | PYPL | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 10 | 63 | 53 pts below |
PYPL has the edge over LLY on valuation relative to its sector.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over PYPL on trend strength, trading above more of its moving averages.
PYPL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.5 | 3.3% above |
| 20 week MA | $55.5 | 5% above |
| 50 week MA | $51.5 | 13% above |
| 100 week MA | $61.6 | 5.4% below |
| 200 week MA | $64.5 | 9.6% below |
PYPL has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 9.6% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over PYPL on returns for 2026, with the stronger performance.
PYPL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $109.4 | $238.6 | +118% |
| 2021 | $238.6 | $192.0 | -20% |
| 2022 | $192.0 | $69.0 | -64% |
| 2023 | $69.0 | $61.4 | -11% |
| 2024 | $61.4 | $86.9 | +41% |
| 2025 | $86.9 | $60.0 | -31% |
| 2026 YTD | $60.0 | $58.3 | -2.8% |
PYPL's yearly returns have swung widely, from +118% in 2020 to −64% in 2022. It's down 2.8% so far in 2026.